SPT Labtech announced a strategic collaboration with Illumina to develop an automated sample‑preparation platform for the MiSeq i100 benchtop sequencer, aiming to bring standardized NGS workflows into decentralized clinical settings. The work focuses on reproducible library prep for oncology and other clinical applications where rapid, high‑quality genomic characterization is needed close to the point of care. Illumina highlighted the growing installed base of the MiSeq i100 and the need for solutions that let smaller labs perform robust NGS without large central facility overhead. SPT Labtech emphasized the partnership will expand its clinical genomics footprint and reduce turnaround times in hospital and regional lab environments. The collaboration addresses a practical gap between high‑throughput core labs and smaller clinical providers, targeting improved control over sample quality and faster diagnostic decisioning.